https://pharmatimes.com in-depth news, features and insights for the pharmaceutical and healthcare sectors Thu, 10 Apr 2025 11:23:34 +0000 en-US hourly 1 https://pharmatimes.com/wp-content/uploads/2023/11/PT-icon-150x150.png https://pharmatimes.com 32 32 232894315 https://pharmatimes.com/news/first-treatment-for-common-bladder-cancer-recommended-by-nice/ Thu, 10 Apr 2025 11:22:53 +0000 https://pharmatimes.com/?p=103110 Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration

]]> 103110 https://pharmatimes.com/news/fda_approves_first_targeted_therapy_for_metastatic_bladder_cancer_1284503/ Tue, 16 Apr 2019 11:55:00 +0000 https://pharmatimes.com/uncategorized/fda_approves_first_targeted_therapy_for_metastatic_bladder_cancer_1284503/ The decision was based on a clinical trial showing an objective response rate of 32.2%.

]]> 63517